{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:38:57Z","timestamp":1790105937626,"version":"4.0.1"},"reference-count":108,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T00:00:00Z","timestamp":1294963200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0015921","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T22:03:37Z","timestamp":1295042617000},"page":"e15921","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":74,"title":["Rise and Fall of an Anti-MUC1 Specific Antibody"],"prefix":"10.1371","volume":"6","author":[{"given":"Holger","family":"Thie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Toleikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"von Wasielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther","family":"Bastert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schirrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Tourais","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian K.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dict","family":"Fournes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"de Romeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"D\u00fcbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,1,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/348552a0","article-title":"Phage antibodies: filamentous phage displaying antibody variable domains.","volume":"348","author":"J McCafferty","year":"1990","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/352624a0","article-title":"Making antibody fragments using phage display libraries.","volume":"352","author":"T Clackson","year":"1991","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1093\/nar\/19.15.4133","article-title":"Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains.","volume":"19","author":"HR Hoogenboom","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-1119(91)90244-6","article-title":"A surface expression vector for antibody screening.","volume":"104","author":"F Breitling","year":"1991","journal-title":"Gene"},{"key":"ref5","article-title":"A human scFv antibody generation pipeline for proteome research.","author":"M Hust","year":"2010"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.tibtech.2010.05.001","article-title":"Generating recombinant antibodies to the complete human proteome.","volume":"28","author":"S D\u00fcbel","year":"2010","journal-title":"Trends Biotechnol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"R254","DOI":"10.1186\/gb-2007-8-11-r254","article-title":"Application of phage display to high throughput antibody generation and characterization.","volume":"8","author":"DJ Schofield","year":"2007","journal-title":"Genome Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1472-6750-9-60","article-title":"Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity.","volume":"9","author":"T Pelat","year":"2009","journal-title":"BMC Biotechnol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-3083.2000.00709.x","article-title":"Neutralizing human anti crotoxin scFv isolated from a nonimmunized phage library.","volume":"51","author":"DF Cardoso","year":"2000","journal-title":"Scand J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1574-695X.1999.tb01253.x","article-title":"Development of neutralising human recombinant antibodies to pertussis toxin.","volume":"23","author":"P Williamson","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1472-6750-8-66","article-title":"Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV).","volume":"8","author":"M Kirsch","year":"2008","journal-title":"BMC Biotechnol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e5476","DOI":"10.1371\/journal.pone.0005476","article-title":"Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.","volume":"4","author":"L Sun","year":"2009","journal-title":"PLoS ONE"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.vetmic.2010.06.023","article-title":"Isolation of scFv fragments specific to OmpD of Salmonella Typhimurium.","volume":"147","author":"T Meyer","year":"2011","journal-title":"Vet Microbiol"},{"key":"ref14","first-page":"581","article-title":"By-passing immunization. Human antibodies from V-gene libraries displayed on phage.","volume":"222","author":"JD Marks","year":"1991","journal-title":"J Mol Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00253-006-0810-y","article-title":"Recombinant therapeutic antibodies.","volume":"74","author":"S D\u00fcbel","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nbt1126","article-title":"Selecting and screening recombinant antibody libraries.","volume":"23","author":"HR Hoogenboom","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/138920108786786349","article-title":"Phage display derived therapeutic antibodies.","volume":"9","author":"H Thie","year":"2008","journal-title":"Curr Pharm Biotechnol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1073\/pnas.89.8.3576","article-title":"In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library.","volume":"89","author":"H Gram","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0022-2836(92)90639-2","article-title":"Selection of phage antibodies by binding affinity. Mimicking affinity maturation.","volume":"226","author":"RE Hawkins","year":"1992","journal-title":"J Mol Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3816\/CBC.2008.n.025","article-title":"Metastatic breast cancer: the treatment challenge.","volume":"8","author":"SE Jones","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1038\/onc.2010.87","article-title":"Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.","volume":"29","author":"S Bafna","year":"2010","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1023\/A:1022260711583","article-title":"MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment.","volume":"18","author":"P Mukherjee","year":"2001","journal-title":"Glycoconj J"},{"key":"ref23","first-page":"304","article-title":"Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers.","volume":"51","author":"H Albrecht","year":"2007","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2009.09.018","article-title":"The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers.","volume":"92","author":"N Jonckheere","year":"2010","journal-title":"Biochimie"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0304-4157(95)00014-3","article-title":"The epithelial mucin, MUC1, of milk, mammary gland and other tissues.","volume":"1241","author":"S Patton","year":"1995","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl","key":"ref26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.2910410809","article-title":"Monoclonal antibodies to epithelial sialomucins recognize epitopes at different cellular sites in adenolymphomas of the parotid gland.","volume":"3","author":"S Zotter","year":"1988","journal-title":"Int J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1073\/pnas.84.17.6060","article-title":"Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium.","volume":"84","author":"SJ Gendler","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/bies.10201","article-title":"Cell signaling through membrane mucins.","volume":"25","author":"KL Carraway","year":"2003","journal-title":"Bioessays"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0014-4827(90)90174-9","article-title":"Determination of apical membrane polarity in mammary epithelial cell cultures: the role of cell-cell, cell-substratum, and membrane-cytoskeleton interactions.","volume":"188","author":"G Parry","year":"1990","journal-title":"Exp Cell Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"15099","DOI":"10.1016\/S0021-9258(18)98592-3","article-title":"Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism.","volume":"266","author":"AP Spicer","year":"1991","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"15286","DOI":"10.1016\/S0021-9258(18)77254-2","article-title":"Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.","volume":"265","author":"SJ Gendler","year":"1990","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.2910440423","article-title":"A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes.","volume":"44","author":"J Burchell","year":"1989","journal-title":"Int J Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"12820","DOI":"10.1016\/S0021-9258(18)37632-4","article-title":"A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.","volume":"263","author":"S Gendler","year":"1988","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/328082a0","article-title":"The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM.","volume":"328","author":"DM Swallow","year":"1987","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/glycob\/10.5.439","article-title":"MUC1: the polymorphic appearance of a human mucin.","volume":"10","author":"FG Hanisch","year":"2000","journal-title":"Glycobiology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1073\/pnas.85.7.2320","article-title":"Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.","volume":"85","author":"J Siddiqui","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF01189075","article-title":"Structures of acidic O-linked polylactosaminoglycans on human skim milk mucins.","volume":"7","author":"FG Hanisch","year":"1990","journal-title":"Glycoconj J"},{"key":"ref38","first-page":"872","article-title":"Structures of neutral O-linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly-N-acetyllactosamine backbones with Gal beta(1-4)GlcNAc beta(1-6) repeating units.","volume":"264","author":"FG Hanisch","year":"1989","journal-title":"J Biol Chem"},{"key":"ref39","first-page":"261","article-title":"Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line.","volume":"1","author":"SR Hull","year":"1989","journal-title":"Cancer Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"L751","DOI":"10.1152\/ajplung.00383.2001","article-title":"Identification of Pseudomonas aeruginosa flagellin as an adhesin for Muc1 mucin.","volume":"282","author":"EP Lillehoj","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1007015312036","article-title":"Intestinal mucins: the binding sites for Salmonella typhimurium.","volume":"204","author":"DB Vimal","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.ph.57.030195.003135","article-title":"Epithelial mucin genes.","volume":"57","author":"SJ Gendler","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/humupd\/5.4.280","article-title":"Mammalian reproductive tract mucins.","volume":"5","author":"E Lagow","year":"1999","journal-title":"Hum Reprod Update"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ijc.2910280104","article-title":"Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.","volume":"28","author":"J Taylor-Papadimitriou","year":"1981","journal-title":"Int J Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00262-006-0135-9","article-title":"PankoMab: a potent new generation anti-tumour MUC1 antibody. Cancer Immunol.","volume":"55","author":"A Danielczyk","year":"2006","journal-title":"Immunother"},{"key":"ref46","first-page":"2582","article-title":"MAM-6 antigen, a new serum marker for breast cancer monitoring.","volume":"46","author":"J Hilkens","year":"1986","journal-title":"Cancer Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0142(19910801)68:3<574::AID-CNCR2820680322>3.0.CO;2-B","article-title":"The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.","volume":"68","author":"F Safi","year":"1991","journal-title":"Cancer"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"33325","DOI":"10.1074\/jbc.271.52.33325","article-title":"Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.","volume":"271","author":"KO Lloyd","year":"1996","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4161\/cbt.6.4.4201","article-title":"MUC1: a target molecule for cancer therapy.","volume":"6","author":"R Singh","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/protein\/gzq044","article-title":"PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1.","volume":"23","author":"S Schoonooghe","year":"2010","journal-title":"Protein Eng Des Sel"},{"key":"ref51","first-page":"364","article-title":"Construction of a reshaped HMFG1 antibody and comparison of its fine specificity with that of the parent mouse antibody.","volume":"78","author":"ME Verhoeyen","year":"1993","journal-title":"Immunology"},{"key":"ref52","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2010.03.006","article-title":"Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas.","author":"X Fan","year":"2010"},{"issue":"Suppl 1","key":"ref53","first-page":"1","article-title":"Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.","volume":"19","author":"MR Price","year":"1998","journal-title":"Tumour Biol"},{"key":"ref54","first-page":"4324","article-title":"Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.","volume":"58","author":"P Henderikx","year":"1998","journal-title":"Cancer Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0002-9440(10)61107-8","article-title":"A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized.","volume":"160","author":"P Henderikx","year":"2002","journal-title":"Am J Pathol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(94)00286-6","article-title":"Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes.","volume":"179","author":"M Welschof","year":"1995","journal-title":"J Immunol Methods"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.94.5.1902","article-title":"The antigen-binding domain of a human IgG-anti-F(ab&apos;)2 autoantibody.","volume":"94","author":"M Welschof","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref58","first-page":"3","article-title":"Analysis of single chain antibody sequences using the VBASE2 Fab analysis tool.","author":"S Mollova","year":"2010"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1128\/AAC.01528-06","article-title":"High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.","volume":"51","author":"T Pelat","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"e6625","DOI":"10.1371\/journal.pone.0006625","article-title":"Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus.","volume":"4","author":"M Sch\u00fctte","year":"2009","journal-title":"PLoS ONE"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jmb.2007.02.100","article-title":"Analyzing the \u201cdegree of humanness\u201d of antibody sequences.","volume":"369","author":"KR Abhinandan","year":"2007","journal-title":"J Mol Biol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jmb.2008.10.033","article-title":"Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering.","volume":"384","author":"T Pelat","year":"2008","journal-title":"J Mol Biol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1158\/1940-6207.CAPR-09-0194","article-title":"Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.","volume":"3","author":"PL Beatty","year":"2010","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/02841860601055441","article-title":"Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival.","volume":"46","author":"O Kurtenkov","year":"2007","journal-title":"Acta Oncol"},{"key":"ref65","first-page":"955","article-title":"A phase I\/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.","volume":"6","author":"AJ Lepisto","year":"2008","journal-title":"Cancer Ther"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2174\/138955709791012283","article-title":"Obtention and engineering of non-human primate (NHP) antibodies for therapeutics.","volume":"9","author":"T Pelat","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jim.2007.10.009","article-title":"Selection of an affinity-matured antibody against a defined epitope by phage display of an immune antibody library.","volume":"329","author":"SJ Kim","year":"2008","journal-title":"J Immunol Methods"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-59745-554-1_16","article-title":"Affinity maturation by phage display.","volume":"525","author":"H Thie","year":"2009","journal-title":"Methods Mol Biol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/1380-2933(96)00044-9","article-title":"Affinity maturation of recombinant antibodies using E. coli mutator cells.","volume":"2","author":"RA Irving","year":"1996","journal-title":"Immunotechnology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/jmbi.1996.0406","article-title":"Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain.","volume":"260","author":"NM Low","year":"1996","journal-title":"J Mol Biol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jim.2004.12.005","article-title":"Affinity maturation of a V(H)H by mutational hotspot randomization.","volume":"297","author":"KYF Yau","year":"2005","journal-title":"J Immunol Methods"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jbiotec.2009.09.022","article-title":"Selection and affinity maturation of human antibodies against rabies virus from a scFv gene library using ribosome display.","volume":"144","author":"X Zhao","year":"2009","journal-title":"J Biotechnol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/bc0603438","article-title":"Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv.","volume":"18","author":"Z Wang","year":"2007","journal-title":"Bioconjug Chem"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.2000.3336","article-title":"Affinity maturation of natural antibody using a chain shuffling technique and the expression of recombinant antibodies in Escherichia coli.","volume":"275","author":"SG Park","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.1073\/pnas.0801221105","article-title":"Affinity maturation of antibodies assisted by in silico modeling.","volume":"105","author":"R Barderas","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"ref76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000056507","article-title":"Affinity of antibodies to MUC1 antigens.","volume":"19","author":"V Karanikas","year":"1998","journal-title":"Tumour Biol"},{"issue":"Suppl 1","key":"ref77","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000056504","article-title":"Epitope characterization of MUC1 antibodies.","volume":"19","author":"A Blockzjil","year":"1998","journal-title":"Tumour Biol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0959-8049(93)90181-E","article-title":"Fine specificity of antibody recognition of carcinoma-associated epithelial mucins: antibody binding to synthetic peptide epitopes.","volume":"29A","author":"S Briggs","year":"1993","journal-title":"Eur J Cancer"},{"key":"ref79","article-title":"Enzyme immunoassays from concept to product development.","author":"S Deshpapnde","year":"1996"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/protein\/gzp073","article-title":"Engineering of stable bispecific antibodies targeting IL-17A and IL-23.","volume":"23","author":"R Mabry","year":"2010","journal-title":"Protein Eng Des Sel"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"12918","DOI":"10.1021\/bi9810407","article-title":"Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.","volume":"37","author":"KM Arndt","year":"1998","journal-title":"Biochemistry"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.febslet.2004.11.011","article-title":"Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers.","volume":"578","author":"MAE Arndt","year":"2004","journal-title":"FEBS Lett"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-2836(02)00403-5","article-title":"Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy.","volume":"320","author":"YC Lee","year":"2002","journal-title":"J Mol Biol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-1759(01)00398-2","article-title":"High-throughput generation and engineering of recombinant human antibodies.","volume":"254","author":"B Krebs","year":"2001","journal-title":"J Immunol Methods"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1111\/j.1742-4658.2009.07129.x","article-title":"Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.","volume":"276","author":"J Muzard","year":"2009","journal-title":"FEBS J"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s12010-009-8699-4","article-title":"Single-chain Fv antibody fragments retain binding properties of the monoclonal antibody raised against peptide P1 of the human prion protein.","volume":"160","author":"N Skrlj","year":"2010","journal-title":"Appl Biochem Biotechnol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/nar\/gkn967","article-title":"Phototoxic aptamers selectively enter and kill epithelial cancer cells.","volume":"37","author":"CSM Ferreira","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/sj.bjc.6602847","article-title":"Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1.","volume":"93","author":"LM Pericleous","year":"2005","journal-title":"Br J Cancer"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s002620050389","article-title":"Comparison of the biological properties of two anti-mucin-1 antibodies prepared for imaging and therapy. Cancer Immunol.","volume":"44","author":"GA Pietersz","year":"1997","journal-title":"Immunother"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.med.58.070605.115320","article-title":"Immunotoxin treatment of cancer.","volume":"58","author":"I Pastan","year":"2007","journal-title":"Annu Rev Med"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4161\/mabs.1.3.8515","article-title":"Antibody drug-conjugates targeting the tumor vasculature: Current and future developments.","volume":"1","author":"H Gerber","year":"2009","journal-title":"MAbs"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2174\/156800909790192365","article-title":"Antibody-drug conjugate targets.","volume":"9","author":"BA Teicher","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.20074","article-title":"Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen.","volume":"61","author":"X Huang","year":"2004","journal-title":"Prostate"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/pros.21164","article-title":"Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity.","volume":"70","author":"K Kuroda","year":"2010","journal-title":"Prostate"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/CJI.0b013e3181ad4d5d","article-title":"Affitoxin\u2014a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.","volume":"32","author":"R Zielinski","year":"2009","journal-title":"J Immunother"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/hyb.2009.0019","article-title":"An internalizing antibody specific for the human asialoglycoprotein receptor.","volume":"28","author":"A Trahtenherts","year":"2009","journal-title":"Hybridoma (Larchmt)"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14712590802631862","article-title":"Targeted therapeutic RNases (ImmunoRNases).","volume":"9","author":"T Schirrmann","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood-2007-04-082768","article-title":"Human antibody RNase fusion protein targeting CD30+ lymphomas.","volume":"111","author":"C Menzel","year":"2008","journal-title":"Blood"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-60761-786-0_11","article-title":"Construction of human antibody gene libraries and selection of antibodies by phage display.","volume":"651","author":"T Schirrmann","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref100","first-page":"45","article-title":"Antibody phage display.","author":"M Hust","year":"2007"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/002215549704501102","article-title":"Tyramine amplification technique in routine immunohistochemistry.","volume":"45","author":"R von Wasielewski","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-6750-7-14","article-title":"Single chain Fab (scFab) fragment.","volume":"7","author":"M Hust","year":"2007","journal-title":"BMC Biotechnol"},{"key":"ref103","article-title":"Molecular cloning: a laboratory manual. 3. ed.","author":"J Sambrook","year":"2001"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-59745-547-3_14","article-title":"Selection of recombinant antibodies from antibody gene libraries.","volume":"408","author":"M Hust","year":"2007","journal-title":"Methods Mol Biol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.nbt.2009.03.004","article-title":"Improved microtitre plate production of single chain Fv fragments in Escherichia coli.","volume":"25","author":"M Hust","year":"2009","journal-title":"N Biotechnol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02789479","article-title":"Regulated secretion and purification of recombinant antibodies in E. coli.","volume":"21","author":"S D\u00fcbel","year":"1992","journal-title":"Cell Biophys"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1016\/S0040-4020(01)85612-X","article-title":"Spot-Synthesis: An easy technique for the positionally addressable, parallel chemical synthesis on a membrane support.","volume":"48","author":"R Frank","year":"1992","journal-title":"Tetrahedron"},{"key":"ref108","first-page":"13","article-title":"The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports\u2014principles and applications.","volume":"267","author":"R Frank","year":"2002","journal-title":"J Immunol Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0015921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T04:20:33Z","timestamp":1712118033000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0015921"}},"subtitle":[],"editor":[{"given":"Hong Wei","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,14]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0015921","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,14]]}}}